Ambrosia Systems is a **health technology company** specializing in **AI-powered diabetes management, continuous glucose monitoring (CGM), metabolic health, and digital healthcare solutions**. Founded in **2016** and headquartered in **San Francisco, California**, the company develops integrated hardware and software platforms that help individuals with diabetes, obesity, and metabolic disorders monitor and improve their health using real-time data and artificial intelligence. Its mission is to make preventive healthcare more personalized, proactive, and accessible worldwide. The company's product portfolio includes the **BluCon NightRider** CGM transmitter, **LinkBluCon** glucose monitoring app, **FollowBluCon** remote caregiver app, **Ambrosia Care** digital health platform, and AI-driven diabetes and weight management services. These solutions connect glucose sensors, wearable devices, and health data to provide real-time glucose monitoring, personalized health insights, lifestyle recommendations, and remote patient support. Ambrosia also offers a platform that enables healthcare providers, fitness professionals, and businesses to launch diabetes and weight-management services using its technology. Ambrosia Systems focuses on improving long-term metabolic health by combining continuous health monitoring with AI-based analytics. The company serves users in more than **100 countries** and collaborates with healthcare professionals, employers, insurers, and wellness providers to deliver data-driven diabetes care and preventive health solutions. Through ongoing innovation in wearable health technology, Ambrosia aims to simplify chronic disease management and empower users to make informed lifestyle decisions. **Simple summary:** Ambrosia Systems is a **digital health technology company** that develops AI-powered continuous glucose monitoring, diabetes management, and metabolic health solutions, helping individuals and healthcare providers improve health outcomes through real-time monitoring and personalized insights.